The Partners of BioMedical Insights have over 60 combined years of industry experience.
Elizabeth K. Brooks, Founding Partner
Ms. Brooks has worked in market research and health care policy for over 20 years. During this time, she has helped numerous biotechnology, pharmaceutical, and medical device companies develop marketing, reimbursement, distribution, and overall launch strategies for their products.
Ms. Brooks has analyzed markets for dozens of medical product companies and has provided due diligence support to numerous investors. She is also expert at reimbursement issues, offering education, analysis, and tactical support to pharmaceutical and biotechnology concerns, as well as medical device companies. In addition, Ms. Brooks has developed a model for helping companies evaluate the need for pharmacoeconomic studies and has trained hundreds of staff on the appropriate use of outcomes research tools.
Ms. Brooks holds a Masters of Business Administration and an Honors Bachelor of Arts degree in English, both from the University of Chicago. She also earned a Certificate from the University of Chicago Graduate Program on Health Administration and Policy.
Paul C. Nagle, Founding Partner
For 20 years, Mr. Nagle has advised medical product manufacturers on a wide range of strategic issues. He specializes in pricing strategy, payer and reimbursement strategy, and assessing markets and products for licensing and M&A due diligence.
Mr. Nagle’s focus is most frequently on the US and Europe, but also includes Japan and Brazil. He frequently consults to the investment community for opportunities under consideration. Mr. Nagle performs pricing analyses and develops pricing and contracting strategies using a variety of methodologies. Mr. Nagle also has significant expertise in third-world market assessments. Mr. Nagle is frequently called upon by his clients to research, analyze and strategize about particularly unique and challenging manufacturer dilemmas and novel areas of interest. Additionally, Mr. Nagle has helped state Medicaid programs and private payers understand the impact of specialty products, and his analyses have impacted Medicare legislation.
Mr. Nagle holds a Bachelor of Science in Business Administration from the Olin School at Washington University in St. Louis. Before co-founding BioMedical Insights, Mr. Nagle was at Health Technology Associates, which became part of Covance.
Christopher A. Nicita, Founding Partner
Mr. Nicita specializes in market and technology assessment, new product planning, and pricing and reimbursement strategy. His business experience, combined with his background in molecular biology research, enables him to understand the scientific and clinical sides of new medical technologies, as well as their commercial potential. He has over 20 years of experience in health care market analysis and medical research.
Mr. Nicita has helped identify and evaluate opportunities afforded by dozens of new products, technologies, and markets and has helped the firm’s clients develop and launch a number of innovative new therapies. He has worked with a range of companies, from industry leaders to start-ups, to make sound portfolio investment decisions and to optimize clinical development strategy. Mr. Nicita frequently consults to companies on prospective in-licensing and merger and acquisition candidates, and has provided due diligence services to a variety of health care investors. He has broad expertise in most therapeutic classes and disease areas including oncology, infectious diseases, immune-mediated and inflammatory diseases, endocrinologic diseases, ultra rare genetic diseases, and cardiovascular diseases, among others.
Mr. Nicita holds a Masters of Business Administration and an Honors Bachelor of Science in Molecular Biology, both from the University of Michigan.